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Aim.Todetermineamonginfantsbornbeforethe28thweekofgestationtowhatextentbloodgasabnormalitiesduringthefirstthree
postnatal days provide information about the risk of bronchopulmonary dysplasia (BPD). Methods. We studied the association of
extremequartilesofbloodgasmeasurements(hypoxemia,hyperoxemia,hypocapnea,andhypercapnea)inthefirstthreepostnatal
days, with bronchopulmonary dysplasia, among 906 newborns, using multivariable models adjusting for potential confounders.
We approximated NIH criteria by classifying severity of BPD on the basis of the receipt of any O2 o np o s t n a t a ld a y2 8a n da t3 6
weeksPMAandassistedven tila tio n.Results.Inmodelsthatdidnotadjustforventilation,hypoxemiawasassociatedwithincreased
risk of severe BPD and very severe BPD, while infants who had hypercapnea were at increased risk of very severe BPD only. In
contrast, infants who had hypocapnea were at reduced risk of severe BPD. Including ventilation for 14 or more days eliminated
the associations with hypoxemia and with hypercapnea and made the decreased risk of very severe BPD statistically significant.
Conclusions. Among ELGANs, recurrent/persistent blood gas abnormalities in the first three postnatal days convey information
about the risk of severe and very severe BPD.
1. Introduction
Despite the improved survival of extremely low gesta-
tional age newborns (ELGANs) defined as infants born at
<28 weeks’ gestation, bronchopulmonary dysplasia (BPD)
remains prevalent and an important healthcare burden to
patients, their families, and society [1–4]. Identifying early,
perhaps remediable, indicators of later pulmonary disorders
has the potential to contribute to the reduction of the risk of
these disorders.
Blood gas abnormalities and acid-base disturbances can
occur as a result of lung immaturity that can be complicated
by comorbidities, such as perinatal infection or pulmonary
hypoplasia [5–10]. Likewise, medical management, including
permissivehypercapnea,alsocanpredispose,intentionallyor
unintentionally, to blood gas abnormalities [11–13].
In the presurfactant era, low PCO2 levels were associated
with increased risk, and high PCO2 levels were associated
with decreased risk of BPD [15–17]. In the postsurfactant era,
BPD has been predicted by oxygen requirement, abnormal
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chest X-ray, and ventilator dependency at 4 days of age [18].
The relationship between early blood gas abnormalities and
the development of BPD has not been well studied since
the wide-spread acceptance of antenatal steroids, surfactant
replacement therapy, and permissive hypercapnea.
The objective of the present study was to examine the
relationshipbetweenbloodgasabnormalitiesinthefirstthree
postnatal days and BPD risk.
2. Subjects and Methods
The ELGAN study was originally designed to detect struc-
tural and functional neurological abnormalities in infants
born before 28 weeks of gestational age at 14 participating
centersintheUSAduringtheyears2002–2004[19].Approval
was obtained from the institutional review board (IRB) at
each participating institution. Consent was obtained from
mothers, either antenatally or after delivery, based on the
human research committee recommendations and/or indi-
vidualclinicalsituation.Of1506infantsenrolled,information
on placental microbiology, blood gases, and BPD diagnosis
was available for 906 infants.
The estimates of gestational age (GA) were based on
availability of information to best determine the most
accurate gestational age. The most accurate GA estimates
were obtained from dates of embryo retrieval, intrauterine
insemination, or by fetal ultrasound prior to 14 weeks (62%).
The next reliable GA estimate was given to fetal ultrasound
at greater than 14 weeks (29%), LMP (7%), and postnatal
estimation of gestational age, as recorded in the neonatal
i n t e n s i v ec a r eu n i tl o gb o o k( 1 % ) .Th eb i r t hw e i g h t𝑍-score
reflects the number of standard deviations the infant’s birth
weight is above or below the median weight of infants of the
same gestational age in a standard data set [14].
We collected all the physiology, laboratory, and therapy
data for the first 12 hours needed to calculate a score for
neonatalacutephysiology(SNAP-II)andascoreforneonatal
acute physiology perinatal extension (SNAPPE-II) [20].
We classified infants by the number of days they received
mechanical ventilation (either high-frequency or conven-
tional mechanical ventilation) from birth to 36 weeks’ post-
menstrual age (PMA). For the analyses presented here, we
limited our analyses to the trichotomy of <7 days, 7–13 days,
and 14 or more days of ventilation.
2.1. Blood Gas Collection and Classification. PO2 and PCO2
were measured almost routinely on the first three postnatal
d a y sa n dw ec o l l e c t e dt h el o w e s t ,m o d a l ,a n dh i g h e s tv a l u e s
on each day [21, 22]. The first postnatal day was defined as
the first 24 hours after delivery plus the additional hours
until midnight. Each successive day then began and ended
at midnight [2]. The median number of blood gases obtained
on each day declined rapidly from 8 on day 1 to 4 on day 3.
With the exception of 7 ELGANs on day 1, 15 ELGANs on
day 2, and 60 ELGANs on day 3 who had venous/capillary
measurements,allothervalueswerefromarterialspecimens.
ELGANs were classified by gestational age (23-24, 25-26,
and 27 weeks) and blood specimens were classified by the
postnatal day they were obtained (1, 2, 3). Quartiles of PaO2
and PCO2 were calculated for each of 9 gestational age and
postnataldaygroups,separatelyforarterialandvenousvalues
(i.e., 18 groups), and blood gases of each infant were assigned
to his/her quartile based on membership in one of these 18
groups. We considered an infant to be exposed to abnormal
blood gas values, if she/he had a measurement in the lowest
quartile and, separately, the highest quartile on at least two of
three postnatal days. Values in the lowest or highest quartile
on just one postnatal day were not considered an exposure.
Because we collected the minimum and maximum blood
gas values each day, we cannot tell if the values of PCO2
and/or PO2 are from the same specimen. Since no protocol
was established for sampling blood gases, all measurements
were obtained at the discretion of the clinical team caring for
each infant.
2.2. Modified Definitions of BPD. Because we did not collect
informationaboutpercentageofoxygendeliveredonpostna-
tal day 28 or at 36 weeks PMA, we could not use NIH criteria
for BPD [23, 24].
We approximated the NIH criteria as best as we could by
replacing <30% and >30% with any oxygen. Thus, mild and
moderateBPDaredefinedasaneedforsupplementaloxygen
≥28 days, but not at 36 weeks PMA, while severe BPD is
defined as a need for supplemental oxygen at 36 weeks PMA,
but not requiring ventilation assistance, and a classification
of very severe BPD required a need for both supplemental
oxygen and ventilation assistance at 36 weeks PMA.
2.3. Placenta. Delivered placentas were placed in a sterile
exam basin and transported to a sampling room, where they
were biopsied under sterile conditions. Eighty-two percent
of the samples were obtained within 1 hour of delivery. The
microbiologic and histologic procedures are described in
detailelsewhere[25,26].Briefly,inflammationwasdefinedas
any of the following four lesions: (a) chorionic plate inflam-
mation of grade 3 (neutrophils up to amnionic epithelium)
and stage 3 (>20 neutrophils/20x), (b) external membrane
inflammation of grade 3 (numerous large or confluent foci
of neutrophils), (c) umbilical cord inflammation of grade 3
or higher (neutrophils in perivascular Wharton’s jelly), and
(d) neutrophilic infiltration into fetal stem vessels in the
chorionic plate.
2.4. Statistical Analysis. We evaluated the hypothesis that
ELGANs who have a blood gas value in an extreme quartile
on at least 2 of the first 3 postnatal days are at increased
risk for developing BPD. Four extremes in blood gases were
considered: lowest and highest quartiles of PO2 and PCO2.
Because only 80 of the 906 infants in our sample did not
have any BPD by our minor modification of NIH criteria,
having this group of infants serve as the referent group for
multivariable analyses prominently limited statistical power.
Consequently, we decided to group these infants who were
not oxygen dependent on day 28 with those who were not
dependent at 36 weeks PMA (𝑁 = 314) to form the referent
group for all multivariable analyses of BPD risk.International Journal of Pediatrics 3
Table 1: The values that define the lowest and highest quartiles of each blood gas on each day in each gestational age group.
Blood gas quartile → Lowest PO2 (mmHg) Highest PO2 (mmHg)
Postnatal day → 123123
Gestational age (wks) ↓
23-24 39 43 44 152 98 104
25-26 42 45 45 145 100 95
27 40 44 46 142 92 96
Blood gas quartile → Lowest PCO2 (mmHg) Highest PCO2 (mmHg)
Postnatal day → 123123
Gestational age (wks) ↓
23-24 27 33 34 65 68 63
25-26 29 35.5 35 60 64 60
27 29 35 36 58 57 56
We selected variables as confounders if in our data they
were associated with both a blood gas extreme and with one
of the pulmonary disorders with probabilities ≤0.25 [27].
After reviewing a broad range of potential confounders, we
foundthatsixvariableswereassociatedwithbothabloodgas
extremeandsevereorverysevereBPD,includingconception
assistance, maternal fever during pregnancy, relative fetal
growth restriction (defined as a birth weight more than one
standard deviation below the expected median), recovery of
Mycoplasma fr omtheplacen ta,andillnessseverityindica tors
(SNAP-II and SNAPPE-II). The number of days ventilated
was also associated with both blood gas disturbances and
BPD ,butweelectednottoincludethisvariableinthetoppart
of Table 4 because it might have been an intervening variable








a n dm o r el i k e l yt oh a v er e c e i v e dt h es a m er e s p i r a t o r yc a r e
thanthosebornatanotherhospital[28].Thecontributionsof
blood gas abnormalities to severity of BPD are given as odds
ratioswith95%confidenceintervals,controllingforpotential
confounders. In an effort to balance the risks of type 1 and
t y p e2e r r o r s ,w h i l ee v a l u a t i n go n l y4h i g h l yr e l a t e db l o o d
gasextremes,wechosetodescribetheprecisionofoddsratio
estimates with 95% confidence intervals.
3. Results
Of the 1506 infants enrolled in the ELGAN Study, 1172 had
blood gas assessments and 906 survived until 36 weeks PMA
and had information about all variables in the multivariable
models. Infants who did not have a blood gas measurement
onall3ofthefirst3postnataldayswerelesslikelythanothers
tohaveahighSNAPPE-II,lowermeanarterialpressures,and
to have had day-2 blood gas measurements that were in an
extreme quartile. Fully 29% had a SNAPPE-II ≥45.
The values that define the lowest and highest quartiles
of PO2 and PCO2 were fairly consistent for all gestational
age groups on all 3 postnatal days (Table 1). By and large,
gestational age groups differed minimally in the boundaries
for what defines an extreme quartile of lowest and highest
PO2and lowest and highest PCO2 quartiles. Invariably, mea-
surements that define an extreme quartile tended to be most
extreme on day 1.
Infants who had an abnormal blood gas measurement
on multiple days were more likely than others to have had
a high SNAPPE-II (Table 2). Newborns who had recur-
rent/persistent hypoxemia were more likely than their peers
to have required 14 or more days of ventilation assistance.
Those who had hypercapnea were more likely than others to
have developed very severe BPD and showed a predilection
tobehavingabirthweightthatwaslowforgestationalage,to
beborntoawomanwhohadfeverduringthepregnancy,and
to have required 14 or more days of ventilation assistance.
The univariable risk profiles of severe and very severe
BPD are similar (Table 3). Both are characterized by a
tendencytoincludeanoverrepresentationofnewbornsinthe
lowest gestational age category, those born to a woman who
experienced fever during this pregnancy, those with a high





for assisted ventilation (Table 4,t o ps e t ) .H y p e r c a p n e ah o w -
ever was associated with ventilator-dependent BPD. Adding
a variable for 14 or more days of ventilation prominently
reduced or eliminated the associations with hypoxemia and
hypercapnea (Table 4, bottom set). On the other hand, doing
sodidnotinfluencetheassociationbetweenhypocapneaand
severeBPDandallowedtheassociationbetweenhypocapnea
and very severe BPD to become statistically significant.
4. Discussion
In the present study, the first of its kind in the surfactant
era, recurring/persistent blood gas abnormalities during the4 International Journal of Pediatrics
Table 2: The distribution of infants who had a blood gas extreme (defined as a PaO2 or PCO2 in the highest or lowest quartile for gestational
age on at least two of the first three postnatal days) listed at the top of each column within strata of potential confounders, listed on the left.
These are column percents.
Potential confounder
Blood gas extreme
Lowest Highest Lowest Highest Row
PaO2 PaO2 PCO2 PCO2
Yes No Yes No Yes No Yes No 𝑁
Gestational age (weeks)
23-24 23 25 24 25 25 24 26 24 223
25-26 47 46 44 47 46 46 44 47 418
27 30 29 32 29 28 30 30 29 265
Birth weight 𝑍-score <−1
§
Yes 25 20 25 20 23 20 30 18 59
Maternal fever
†
Yes 8 6 7 6 7 7 10 5 209
Placenta Mycoplasma
Yes 9 10 10 10 14 9 7 11 109
SNAPPE-II ≥45
Yes 33 28 37 28 34 28 47 24 263
Days ventilated
<71 4 2 2 1 9 2 1 2 1 2 0 6 2 5 1 8 6
7–13 9 11 8 11 9 10 10 10 92
14+ 77 67 74 68 69 69 84 65 628
BPD
None 9 9 8 9 9 9 7 9 80
Mild/moderate 30 36 33 35 42 32 25 37 314
Severe 47 45 48 45 39 48 50 44 474
Very severe 14 10 11 11 9 11 17 9 98
Maximum column 𝑁 195 711 189 717 201 705 197 709 906
§Birth weight 𝑍-scores based on Yudkin et al. [14]s t a n d a r d .
†Maternal temperature >100.4∘Fd u r i n gp r e g n a n c y .
first three postnatal days convey information about the risk
of severe and very severe BPD in ELGANs above and beyond
the information conveyed by indicators of prematurity and
risk of dying. The finding that some of the risk information is
diminished when intervening ventilation is considered sug-
gests that some of the blood gas disturbances are indicative
of the need for ventilation, which in turn contributes to such
late respiratory disorders as BPD.
In the ELGAN study sample, blood gas abnormalities
on two of the first three postnatal days were associated
with sustained or recurrent systemic inflammation in the
week and a half that followed [22]. In addition, “prolonged”
ventilation,definedasventilationon14ormoredaysbetween
birth and 36 weeks PMA, was also associated with sustained
or recurrent early systemic inflammation [29]a n de a r l y
sustained or recurrent systemic inflammation was associated
with heightened BPD risk [30]. Consequently, we hypothe-
sized that the blood gas derangements that predicted BPD
probably contributed to BPD via an increased likelihood
of “prolonged” ventilation, which, in turn, might promote
inflammation [29]. The differences seen between the two
sets of Table 4, which reflect addition of only the ventilation
variable to multivariable models of BPD risks, indicate that
ventilation is likely to be an intermediary between the blood
gas derangements and the BPD.
I nap r e v i o u ss t u d y ,c o m p o n e n t so fS N A P - I Ic o n t r i b u t e d
to the prediction of the need for CPAP and/or ventilator
assistance 72 hours after birth among newborns whose
gestational age was ≥34 weeks [31]. Thus, we consider the
SNAPPE-IIworthyofinclusionamongvariablesadjustingfor
endogenous risk of BPD in ELGANs.
A previous study found an association between early
hypercapnea and BPD [32], while another found an asso-
ciation between hypercapnea and BPD but only among the
premature infants whose clinical course complicated by PDA
[4]. We, too, found that hypercapnea was associated with
very severe BPD, but not with severe BPD. The association
with very severe BPD was diminished and lost its statisti-
cal significance when we added a variable for duration of
ventilation. These findings are compatible with the view that
the association of hypercapnea with very severe BPD reflects
phenomena associated with prolonged ventilation, perhaps
more than early gas adjustments.
TheapparentprotectiveeffectofhypocapneaagainstBPD
in the present study is in contrast to a report from the early
surfactant era that hypocapnea before surfactant therapy wasInternational Journal of Pediatrics 5
Table 3: The distribution of infants who had the form of bronchopulmonary dysplasia listed at the top of each column within strata of





Mild/moderate Severe Very severe
O2 O2 − no vent O2 +v e n t
at 28weeks at 36weeks at 36weeks 𝑁
Gestational age (weeks)
23-24 0 17 33 34 223
25-26 30 50 45 52 418
27 70 33 22 14 265
Maternal fever
†
Yes 10 11 25 41 59
Birth weight 𝑍-score <−1
§
Yes 6 66 7 209
Placenta Mycoplasma
Yes 10 12 10 5 109
SNAPPE-II ≥45
Yes 6 20 36 49 263
Days ventilated
<76 6 3 2 8 0 1 8 6
7–13 20 16 6 2 92
14 14 52 86 98 628
PaO2 quartile on ≥2d a y s
Lowest 23 18 22 29 195
Highest 19 20 22 21 189
PCO2 quartile on ≥2d a y s
Lowest 23 27 19 19 201
Highest 18 16 24 35 197
Maximum column 𝑁 80 314 414 98 906
§Birth weight 𝑍-scores based on Yudkin et al. [14]s t a n d a r d .
†Maternal temperature >100.4
∘Fd u r i n gp r e g n a n c y .
associated with an increased risk of BPD [15]. It is unclear
how hypocapnea might protect against BPD.
We are reluctant to infer that exposure to the observed
blood gas extremes contributed to BPD. Rather, we consider
it highly probable that the blood gas extremes are the first
indicators of the severity of the respiratory dysfunction that
will result in severe and very severe BPD. Nevertheless, we
are not yet prepared to dismiss the possibility that improved
care to minimize the occurrence of some of the blood gas
abnormalities might reduce the occurrence of severe BPD.
We minimized confounding by indication. To avoid
attributing to hypocarbia what might more appropriately
be attributed to its antecedents, one group of investigators
created a hypocarbia propensity score when evaluating the
presumed consequences of hypocarbia [33].
Among the variables that comprised the propensity score
were low gestational age <26 weeks, low birth-weight 𝑍-
s c o r e ,a n dv e n t i l a t i o n .W ei n c l u d e dt h e s ei nm u l t i v a r i a b l e
m o d e l so fB P Dr i s k .O t h e rp r o p e n s i t ys c o r ec o m p o n e n t s ,
including labor, membrane rupture, maternal leukocytosis,
and antenatal antibiotic treatment, are closely related to
other variables we adjusted for (e.g., maternal fever during
pregnancy and recovery of Mycoplasma from the placenta).
Similarly, such hypocarbia propensity score components
such as systemic hypotension on day 1, neonatal leukopenia
on day 1, and administration of volume expanders and/or
vasopressors on day 1, are closely related to high values
of SNAPPE-II. Consequently, to a considerable extent we
have approximated the hypocarbia-propensity score used
previously. We acknowledge that our efforts might not have
achieved the goal we set for our multivariable analyses.
Compared to infants exposed to pressure-limited venti-
lation equipment, those treated with volume-targeted ven-
tilation have lower rates of hypocarbia, and the combined
outcome of BPD/death [34, 35]. These types of findings
appear to be contributing to a replacement of pressure-
limited ventilation equipment with volume-targeted equip-
ment. Such changes in ventilation might contribute to a
reduced occurrence of BPD [36].
Our study is not without limitations. Our findings are
based on post hoc analyses of data collected for a study of
indicators of brain damage in ELGANs [19]. The boundaries
for blood gas extremes were pooled values available for all
ELGANs involved in this study who happened to have a
wide range of respiratory illness severity. In addition, our
definition of hypoxemia is not severe at all. Children, who
died of their severe respiratory dysfunction before a BPD
diagnosis could be made, are not included in the analyses.
Wedidnothaveanyspecificindextoevaluatetheassociation
between subsequent BPD and volutrauma/barotrauma. As6 International Journal of Pediatrics
Table 4: Odds ratios (and 95% confidence intervals)
§ of the
associationbetweenbloodgasabnormalities(definedastheextreme
quartile for gestational age on at least two of the first three days)
and BPD. The referent group consists of all infants who did not
have severe or very severe BPD. The sets of tables differ in the
inclusion/exclusion of one variable in the multivariable models. In
the top set, days of ventilation during the NICU stay (<7, 7–13, ≥14)
are not included in the model, while this variable is included in the
bottom set.




Low PO2 High PO2 Low PCO2 High PCO2
Severe 1.5 (1.02, 2.3) 0.9 (0.6, 1.4) 0.6 (0.4, 0.96) 1.3 (0.9, 2.0)
Very
severe
2.5 (1.3, 5.0) 0.7 (0.3, 1.5) 0.5 (0.3, 1.03) 2.5 (1.2, 5.0)




Low PO2 High PO2 Low PCO2 High PCO2
Severe 1.2 (0.8, 1.9) 0.9 (0.6, 1.5) 0.6 (0.4, 0.96) 0.9 (0.6, 1.5)
Very
severe
1.7 (0.8, 3.5) 0.8 (0.3, 1.8) 0.4 (0.2, 0.9) 1.9 (0.9, 4.2)
§All models are adjusted for conception assistance, maternal fever during
pregnancy, birth weight 𝑍-score <−1, recovery of a Mycoplasma from
the placenta, and SNAPPE ≥45. These models also include a hospital
group/cluster term to account for the possibility that infants born at a
particular hospital are more like each other than infants born at other
hospitals.
with all observational studies, we are unable to distinguish
between causation and association as explanations for what
we found. Finally, even though we included SNAPPE-II
scores in our multivariate regression models, we cannot
completely rule out that the sickest infants were more likely
to be treated aggressively than others who were not quite so
sick, making our study prone to confounding by indication
[37, 38].
Our study has several strengths. First, we included a
l a r g en u m b e ro fi n f a n t s ,m a k i n gi tu n l i k e l yt h a tw em i s s e d
important associations due to lack of statistical power, or
claimed associations that might have reflected the instability
of small numbers. Second, we selected infants based on
gestational age, not birth weight, in order to minimize
confounding due to factors related to fetal growth restriction
[39] .Th i si se s pec iall yi m po rta n ti nl i gh to fth ei n c r ea sedri s k
of BPD among infants in the ELGAN study who were born
with severe growth restriction [30]. Third, we collected all of
our data prospectively.
In conclusion, blood gas abnormalities in the first three
postnatal days were associated with BPD, but adding a
variablefordurationofventilationtothemultivariablemodel
left only hypocapnea associated with BPD. One reasonable
implication of these findings is that hypoxemia and hyper-
capnea are probably not in the causal chain leading to BPD.
Rather, they are likely indicators of the need for ventilation,
which is more likely to contribute to BPD risk.
Another implication of our findings is that hypocapnea is
also probably not in the causal chain. Future studies are rec-
ommendedtoidentifywhyhypocapneaconveysinformation
a b o u tt h er e d u c e dr i s ko fB P D .
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